Market Research Logo

North America and Europe Human Coagulation Factor VIII Market by Manufacturers, Regions, Type and Application, Forecast to 2023

North America and Europe Human Coagulation Factor VIII Market by Manufacturers, Regions, Type and Application, Forecast to 2023

Human Coagulation Factor VIII is an essential blood-clotting protein, also known as anti-hemophilic factor (AHF). In humans, factor VIII is encoded by the F8 gene, defects in this gene results in hemophilia A.

Scope of the Report:
This report focuses on the Human Coagulation Factor VIII in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufacturers, countries/Regions, type and application.
Market Segment by Manufacturers, this report covers
Shire (Baxter)
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS

Market Segment by Countries, covering
United States
United Kingdom
Canada
Germany
France
Italy
Spain

Market Segment by Type, covers
Recombinant Factor VIII
Plasma-derived Factor VIII

Market Segment by Applications, can be divided into
Hemophilia A
Spontanous / Trauma
Spontanous / Trauma
Other

There are 19 Chapters to deeply display the North America and Europe Human Coagulation Factor VIII market.

Chapter 1, to describe Human Coagulation Factor VIII Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Human Coagulation Factor VIII, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America and Europe market by countries, covering United States, United Kingdom, Canada, France, Germany, Italy and Spain, with sales, price, revenue and market share of Human Coagulation Factor VIII, for each country, from 2013 to 2018;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2013 to 2018;

Chapter 7, 8, 9, 10, 11, 12 and 13 to analyze the key countries by manufacturers, Type and Application, covering 7 countries, with sales, revenue and market share by manufacturers, types and applications;

Chapter 14, Human Coagulation Factor VIII market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2018 to 2023;

Chapter 15, to analyze the manufacturing cost, key raw materials and manufacturing process, etc.

Chapter 16, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 17, to describe sales channel, distributors, traders, dealers, etc.

Chapter 18 and 19, to describe the research findings and conclusion, appendix, methodology and data source.


1 Market Overview
1.1 Human Coagulation Factor VIII Introduction
1.2 Market Analysis by Type
1.2.1 Recombinant Factor VIII
1.2.2 Plasma-derived Factor VIII
1.3 Market Analysis by Applications
1.3.1 Hemophilia A
1.3.2 Spontanous / Trauma
1.3.3 Spontanous / Trauma
1.3.4 Other
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2013-2023)
1.4.2 Canada Status and Prospect (2013-2023)
1.4.3 United Kingdom Status and Prospect (2013-2023)
1.4.4 Germany Status and Prospect (2013-2023)
1.4.5 France Status and Prospect (2013-2023)
1.4.6 Italy Status and Prospect (2013-2023)
1.4.7 Spain Status and Prospect (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Shire (Baxter)
2.1.1 Business Overview
2.1.2 Human Coagulation Factor VIII Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Shire (Baxter) Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bayer
2.2.1 Business Overview
2.2.2 Human Coagulation Factor VIII Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Bayer Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 CSL
2.3.1 Business Overview
2.3.2 Human Coagulation Factor VIII Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 CSL Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Pfizer
2.4.1 Business Overview
2.4.2 Human Coagulation Factor VIII Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Pfizer Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Grifols
2.5.1 Business Overview
2.5.2 Human Coagulation Factor VIII Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Grifols Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Biogen
2.6.1 Business Overview
2.6.2 Human Coagulation Factor VIII Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Biogen Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Octapharma
2.7.1 Business Overview
2.7.2 Human Coagulation Factor VIII Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Octapharma Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 NovoNordisk
2.8.1 Business Overview
2.8.2 Human Coagulation Factor VIII Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 NovoNordisk Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Greencross
2.9.1 Business Overview
2.9.2 Human Coagulation Factor VIII Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Greencross Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Kedrion
2.10.1 Business Overview
2.10.2 Human Coagulation Factor VIII Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Kedrion Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 BPL
2.11.1 Business Overview
2.11.2 Human Coagulation Factor VIII Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 BPL Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Hualan Bio
2.12.1 Business Overview
2.12.2 Human Coagulation Factor VIII Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Hualan Bio Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 RAAS
2.13.1 Business Overview
2.13.2 Human Coagulation Factor VIII Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 RAAS Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 North America and Europe Human Coagulation Factor VIII Market Competition, by Manufacturer
3.1 North America and Europe Human Coagulation Factor VIII Sales and Market Share by Manufacturer (2016-2017)
3.2 North America and Europe Human Coagulation Factor VIII Revenue and Market Share by Manufacturer (2016-2017)
3.2.1 North America and Europe Human Coagulation Factor VIII Revenue by Manufacturer (2016-2017)
3.2.2 North America and Europe Human Coagulation Factor VIII Revenue Market Share by Manufacturer (2016-2017)
3.3 North America and Europe Human Coagulation Factor VIII Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Human Coagulation Factor VIII Manufacturer Market Share (2016-2017)
3.4.2 Top 5 Human Coagulation Factor VIII Manufacturer Market Share (2016-2017)
3.5 Market Competition Trend
4 North America and Europe Human Coagulation Factor VIII Market Analysis by Countries/Regions
4.1 North America and Europe Human Coagulation Factor VIII Sales Market Share by Countries/Regions
4.2 North America and Europe Human Coagulation Factor VIII Sales by Countries/Regions (2013-2018)
4.2.1 North America and Europe Human Coagulation Factor VIII Sales by Countries/Regions (2013-2018)
4.2.2 North America and Europe Human Coagulation Factor VIII Sales Market Share by Countries (2013-2018)
4.3 North America and Europe Human Coagulation Factor VIII Revenue (Value) by Countries (2013-2018)
4.3.1 North America and Europe Human Coagulation Factor VIII Revenue and Growth Rate (2013-2018)
4.3.2 North America and Europe Human Coagulation Factor VIII Revenue Market Share by Countries (2013-2018)
5 North America and Europe Market Segmentation Human Coagulation Factor VIII by Type
5.1 North America and Europe Human Coagulation Factor VIII Sales, Revenue and Market Share by Type (2013-2018)
5.1.1 North America and Europe Human Coagulation Factor VIII Sales and Market Share by Type (2013-2018)
5.1.2 North America and Europe Human Coagulation Factor VIII Revenue and Market Share by Type (2013-2018)
5.2 Recombinant Factor VIII Sales Growth and Price
5.2.1 North America and Europe Recombinant Factor VIII Sales Growth (2013-2018)
5.2.2 North America and Europe Recombinant Factor VIII Price (2013-2018)
5.3 Plasma-derived Factor VIII Sales Growth and Price
5.3.1 North America and Europe Plasma-derived Factor VIII Sales Growth (2013-2018)
5.3.2 North America and Europe Plasma-derived Factor VIII Price (2013-2018)
6 North America and Europe Market Segmentation Human Coagulation Factor VIII by Application
6.1 North America and Europe Human Coagulation Factor VIII Sales Market Share by Application (2013-2018)
6.2 Hemophilia A Sales Growth (2013-2018)
6.3 Spontanous / Trauma Sales Growth (2013-2018)
6.4 Spontanous / Trauma Sales Growth (2013-2018)
6.5 Other Sales Growth (2013-2018)
7 United States Human Coagulation Factor VIII Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Human Coagulation Factor VIII Revenue, Sales and Growth Rate (2013-2018)
7.2 United States Human Coagulation Factor VIII Sales and Market Share by Type (2013-2018)
7.2.1 United States Human Coagulation Factor VIII Sales by Type (2013-2018)
7.2.2 United States Human Coagulation Factor VIII Sales Market Share by Type (2013-2018)
7.3 United States Human Coagulation Factor VIII Sales and Market Share by Application (2013-2018)
7.3.1 United States Human Coagulation Factor VIII Sales by Application (2013-2018)
7.3.2 United States Human Coagulation Factor VIII Sales Market Share by Application (2013-2018)
7.4 United States Human Coagulation Factor VIII Sales, Revenue and Market Share by Manufacturer (2016-2017)
7.4.1 United States Human Coagulation Factor VIII Sales and Market Share by Manufacturer (2016-2017)
7.4.2 United States Human Coagulation Factor VIII Revenue and Market Share by Manufacturer (2016-2017)
7.5 United States Human Coagulation Factor VIII Export and Import (2013-2018)
8 United Kingdom Human Coagulation Factor VIII Sales, Revenue, by Type, Application and Manufacturers
8.1 United Kingdom Human Coagulation Factor VIII Revenue, Sales and Growth Rate (2013-2018)
8.2 United Kingdom Human Coagulation Factor VIII Sales and Market Share by Type (2016-2017)
8.2.1 United Kingdom Human Coagulation Factor VIII Sales by Type (2013-2018)
8.2.2 United Kingdom Human Coagulation Factor VIII Sales Market Share by Type (2013-2018)
8.3 United Kingdom Human Coagulation Factor VIII Sales and Market Share by Application (2013-2018)
8.3.1 United Kingdom Human Coagulation Factor VIII Sales by Application (2013-2018)
8.3.2 United Kingdom Human Coagulation Factor VIII Sales Market Share by Application (2013-2018)
8.4 United Kingdom Human Coagulation Factor VIII Sales, Revenue and Market Share by Manufacturer (2016-2017)
8.4.1 United Kingdom Human Coagulation Factor VIII Sales and Market Share by Manufacturer (2016-2017)
8.4.2 United Kingdom Human Coagulation Factor VIII Revenue and Market Share by Manufacturer (2016-2017)
8.5 United Kingdom Human Coagulation Factor VIII Export and Import (2013-2018)
9 Canada Human Coagulation Factor VIII Sales, Revenue, by Type, Application and Manufacturers
9.1 Canada Human Coagulation Factor VIII Revenue, Sales and Growth Rate (2013-2018)
9.2 Canada Human Coagulation Factor VIII Sales and Market Share by Type (2013-2018)
9.2.1 Canada Human Coagulation Factor VIII Sales by Type (2013-2018)
9.2.2 Canada Human Coagulation Factor VIII Sales Market Share by Type (2013-2018)
9.3 Canada Sales and Market Share by Application (2013-2018)"
9.3.1 Canada Human Coagulation Factor VIII Sales by Application (2013-2018)
9.3.2 Canada Human Coagulation Factor VIII Sales Market Share by Application (2013-2018)
9.4 Canada Human Coagulation Factor VIII Sales, Revenue and Market Share by Manufacturer (2016-2017)
9.4.1 Canada Human Coagulation Factor VIII Sales and Market Share by Manufacturer (2016-2017)
9.4.2 Canada Human Coagulation Factor VIII Revenue and Market Share by Manufacturer (2016-2017)
9.5 Canada Human Coagulation Factor VIII Export and Import (2013-2018)
10 Germany Human Coagulation Factor VIII Sales, Revenue, by Type, Application and Manufacturers
10.1 Germany Human Coagulation Factor VIII Revenue, Sales and Growth Rate (2013-2018)
10.2 Germany Human Coagulation Factor VIII Sales and Market Share by Type (2013-2018)
10.2.1 Germany Human Coagulation Factor VIII Sales by Type (2013-2018)
10.2.2 Germany Human Coagulation Factor VIII Sales Market Share by Type (2013-2018)
10.3 Germany Human Coagulation Factor VIII Sales and Market Share by Application (2013-2018)
10.3.1 Germany Human Coagulation Factor VIII Sales by Application (2013-2018)
10.3.2 Germany Human Coagulation Factor VIII Sales Market Share by Application (2013-2018)
10.4 Germany Human Coagulation Factor VIII Sales, Revenue and Market Share by Manufacturer (2016-2017)
10.4.1 Germany Human Coagulation Factor VIII Sales and Market Share by Manufacturer (2016-2017)
10.4.2 Germany Human Coagulation Factor VIII Revenue and Market Share by Manufacturer (2016-2017)
10.5 Germany Human Coagulation Factor VIII Export and Import (2013-2018)
11 France Human Coagulation Factor VIII Sales, Revenue, by Type, Application and Manufacturers
11.1 France Human Coagulation Factor VIII Revenue, Sales and Growth Rate (2013-2018)
11.2 France Human Coagulation Factor VIII Sales and Market Share by Type (2013-2018)
11.2.1 France Human Coagulation Factor VIII Sales by Type (2013-2018)
11.2.2 France Human Coagulation Factor VIII Sales Market Share by Type (2013-2018)
11.3 France Sales by Application (2013-2018)"
11.3.1 France Human Coagulation Factor VIII Sales by Application (2013-2018)
11.3.2 France Human Coagulation Factor VIII Sales Market Share by Application (2013-2018)
11.4 France Human Coagulation Factor VIII Sales, Revenue and Market Share by Manufacturer (2016-2017)
11.4.1 France Human Coagulation Factor VIII Sales and Market Share by Manufacturer (2016-2017)
11.4.2 France Human Coagulation Factor VIII Revenue and Market Share by Manufacturer
11.5 France Human Coagulation Factor VIII Export and Import (2013-2018)
12 Italy Human Coagulation Factor VIII Sales, Revenue, by Type, Application and Manufacturers
12.1 Italy Human Coagulation Factor VIII Revenue, Sales and Growth Rate (2013-2018)
12.2 Italy Human Coagulation Factor VIII Sales and Market Share by Type (2013-2018)
12.2.1 Italy Human Coagulation Factor VIII Sales by Type (2013-2018)
12.2.2 Italy Human Coagulation Factor VIII Sales Market Share by Type (2013-2018)
12.3 Italy Human Coagulation Factor VIII Sales and Market Share by Application (2013-2018)
12.3.1 Italy Human Coagulation Factor VIII Sales by Application (2013-2018)
12.3.2 Italy Human Coagulation Factor VIII Sales Market Share by Application (2013-2018)
12.4 Italy Human Coagulation Factor VIII Sales, Revenue and Market Share by Manufacturer (2016-2017)
12.4.1 Italy Human Coagulation Factor VIII Sales and Market Share by Manufacturer (2016-2017)
12.4.2 Italy Human Coagulation Factor VIII Revenue and Market Share by Manufacturer (2016-2017)
12.5 Italy Human Coagulation Factor VIII Export and Import (2013-2018)
13 Spain Human Coagulation Factor VIII Sales, Revenue, by Type, Application and Manufacturers
13.1 Spain Human Coagulation Factor VIII Revenue, Sales and Growth Rate (2013-2018)
13.2 Spain Human Coagulation Factor VIII Sales and Market Share by Type (2013-2018)
13.2.1 Spain Human Coagulation Factor VIII Sales by Type (2013-2018)
13.2.2 Spain Human Coagulation Factor VIII Sales Market Share by Type (2013-2018)
13.3 Spain Human Coagulation Factor VIII Sales by Application (2013-2018)
13.3.1 Spain Human Coagulation Factor VIII Sales by Application (2013-2018)
13.3.2 Spain Human Coagulation Factor VIII Sales Market Share by Application (2013-2018)
13.4 Spain Human Coagulation Factor VIII Sales, Revenue and Market Share by Manufacturer (2016-2017)
13.4.1 Spain Human Coagulation Factor VIII Sales and Market Share by Manufacturer (2016-2017)
13.4.2 Spain Human Coagulation Factor VIII Revenue and Market Share by Manufacturer (2016-2017)
13.5 Spain Human Coagulation Factor VIII Export and Import (2013-2018)
14 Human Coagulation Factor VIII Market Forecast (2018-2023)
14.1 North America and Europe Human Coagulation Factor VIII Sales, Revenue and Growth Rate (2018-2023)
14.2 Human Coagulation Factor VIII Market Forecast by Countries/Regions (2018-2023)
14.2.1 United States Human Coagulation Factor VIII Sales and Growth Rate Forecast (2018-2023)
14.2.2 United Kingdom Human Coagulation Factor VIII Sales and Growth Rate Forecast (2018-2023)
14.2.3 Canada Human Coagulation Factor VIII Sales and Growth Rate Forecast (2018-2023)
14.2.4 Germany Human Coagulation Factor VIII Sales and Growth Rate Forecast (2018-2023)
14.2.5 France Human Coagulation Factor VIII Sales and Growth Rate Forecast (2018-2023)
14.2.6 Italy Human Coagulation Factor VIII Sales and Growth Rate Forecast (2018-2023)
14.2.7 Spain Human Coagulation Factor VIII Sales and Growth Rate Forecast (2018-2023)
14.3 Human Coagulation Factor VIII Market Forecast by Type (2018-2023)
14.3.1 North America and Europe Human Coagulation Factor VIII Sales Forecast by Type (2018-2023)
14.3.2 North America and Europe Human Coagulation Factor VIII Market Share Forecast by Type (2018-2023)
14.4 Human Coagulation Factor VIII Market Forecast by Application (2018-2023)
14.4.1 North America and Europe Human Coagulation Factor VIII Sales Forecast by Application (2018-2023)
14.4.2 North America and Europe Human Coagulation Factor VIII Market Share Forecast by Application (2018-2023)
15 Human Coagulation Factor VIII Manufacturing Cost Analysis
15.1 Human Coagulation Factor VIII Key Raw Materials Analysis
15.1.1 Key Raw Materials
15.1.2 Price Trend of Key Raw Materials
15.1.3 Key Suppliers of Raw Materials
15.1.4 Market Concentration Rate of Raw Materials
15.2 Proportion of Manufacturing Cost Structure
15.2.1 Raw Materials
15.2.2 Labor Cost
15.2.3 Manufacturing Expenses
15.3 Manufacturing Process Analysis of Human Coagulation Factor VIII
16 Industrial Chain, Sourcing Strategy and Downstream Buyers
16.1 Human Coagulation Factor VIII Industrial Chain Analysis
16.2 Upstream Raw Materials Sourcing
16.3 Raw Materials Sources of Human Coagulation Factor VIII Major Manufacturers in 2017
16.4 Downstream Buyers
17 Sales Channel, Distributors, Traders and Dealers
17.1 Sales Channel
17.1.1 Direct Marketing
17.1.2 Indirect Marketing
17.1.3 Marketing Channel Future Trend
17.2 Distributors, Traders and Dealers
18 Research Findings and Conclusion
19 Appendix
19.1 Methodology
19.2 Data Source
List of Tables and Figures
Figure Human Coagulation Factor VIII Picture
Table Product Specifications of Human Coagulation Factor VIII
Figure North America and Europe Sales Market Share of Human Coagulation Factor VIII by Types in 2017
Table Types of Human Coagulation Factor VIII
Figure Recombinant Factor VIII Picture
Figure Plasma-derived Factor VIII Picture
Figure North America and Europe Human Coagulation Factor VIII Sales Market Share by Applications in 2017
Table Applications of Human Coagulation Factor VIII
Figure Hemophilia A Picture
Figure Spontanous / Trauma Picture
Figure Spontanous / Trauma Picture
Figure Other Picture
Figure United States Human Coagulation Factor VIII Revenue (Million USD) and Growth Rate (2013-2023)
Figure Canada Human Coagulation Factor VIII Revenue (Million USD) and Growth Rate (2013-2023)
Figure United Kingdom Human Coagulation Factor VIII Revenue (Million USD) and Growth Rate (2013-2023)
Figure Germany Human Coagulation Factor VIII Revenue (Million USD) and Growth Rate (2013-2023)
Figure France Human Coagulation Factor VIII Revenue (Million USD) and Growth Rate (2013-2023)
Figure Italy Human Coagulation Factor VIII Revenue (Million USD) and Growth Rate (2013-2023)
Figure Spain Human Coagulation Factor VIII Revenue (Million USD) and Growth Rate (2013-2023)
Table Shire (Baxter) Basic Information, Manufacturing Base and Competitors
Table Shire (Baxter) Human Coagulation Factor VIII Type and Applications
Table Shire (Baxter) Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Human Coagulation Factor VIII Type and Applications
Table Bayer Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CSL Basic Information, Manufacturing Base and Competitors
Table CSL Human Coagulation Factor VIII Type and Applications
Table CSL Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Human Coagulation Factor VIII Type and Applications
Table Pfizer Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Grifols Basic Information, Manufacturing Base and Competitors
Table Grifols Human Coagulation Factor VIII Type and Applications
Table Grifols Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biogen Basic Information, Manufacturing Base and Competitors
Table Biogen Human Coagulation Factor VIII Type and Applications
Table Biogen Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Octapharma Basic Information, Manufacturing Base and Competitors
Table Octapharma Human Coagulation Factor VIII Type and Applications
Table Octapharma Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table NovoNordisk Basic Information, Manufacturing Base and Competitors
Table NovoNordisk Human Coagulation Factor VIII Type and Applications
Table NovoNordisk Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Greencross Basic Information, Manufacturing Base and Competitors
Table Greencross Human Coagulation Factor VIII Type and Applications
Table Greencross Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Kedrion Basic Information, Manufacturing Base and Competitors
Table Kedrion Human Coagulation Factor VIII Type and Applications
Table Kedrion Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BPL Basic Information, Manufacturing Base and Competitors
Table BPL Human Coagulation Factor VIII Type and Applications
Table BPL Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Hualan Bio Basic Information, Manufacturing Base and Competitors
Table Hualan Bio Human Coagulation Factor VIII Type and Applications
Table Hualan Bio Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table RAAS Basic Information, Manufacturing Base and Competitors
Table RAAS Human Coagulation Factor VIII Type and Applications
Table RAAS Human Coagulation Factor VIII Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America and Europe Human Coagulation Factor VIII Sales by Manufacturer (2016-2017)
Figure North America and Europe Human Coagulation Factor VIII Sales Market Share by Manufacturer in 2016
Figure North America and Europe Human Coagulation Factor VIII Sales Market Share by Manufacturer in 2017
Table North America and Europe Human Coagulation Factor VIII Revenue by Manufacturer (2016-2017)
Table North America and Europe Human Coagulation Factor VIII Revenue Market Share by Manufacturer (2016-2017)
Figure North America and Europe Human Coagulation Factor VIII Revenue Market Share by Manufacturer in 2016
Figure North America and Europe Human Coagulation Factor VIII Revenue Market Share by Manufacturer in 2017
Table North America and Europe Human Coagulation Factor VIII Price by Manufacturers (2016-2017)
Figure Top 3 Human Coagulation Factor VIII Manufacturer Market Share in 2016
Figure Top 3 Human Coagulation Factor VIII Manufacturer Market Share in 2017
Figure Top 5 Human Coagulation Factor VIII Manufacturer Market Share in 2016
Figure Top 5 Human Coagulation Factor VIII Manufacturer Market Share in 2017
Figure North America and Europe Human Coagulation Factor VIII Sales and Growth (2013-2018)
Table North America and Europe Human Coagulation Factor VIII Sales by Countries/Regions (2013-2018)
Table North America and Europe Human Coagulation Factor VIII Sales Market Share by Countries (2013-2018)
Figure North America and Europe Human Coagulation Factor VIII Sales Market Share by Countries in 2013
Figure North America and Europe Human Coagulation Factor VIII Sales Market Share by Countries in 2017
Figure North America and Europe Human Coagulation Factor VIII Revenue and Growth Rate (2013-2018)
Table North America and Europe Human Coagulation Factor VIII Revenue by Countries (2013-2018)
Table North America and Europe Human Coagulation Factor VIII Revenue Market Share by Countries (2013-2018)
Figure North America and Europe Human Coagulation Factor VIII Revenue Market Share by Countries in 2013
Figure North America and Europe Human Coagulation Factor VIII Revenue Market Share by Countries in 2017
Table North America and Europe Human Coagulation Factor VIII Sales by Type (2013-2018)
Table North America and Europe Human Coagulation Factor VIII Sales Share by Type (2013-2018)
Table North America and Europe Human Coagulation Factor VIII Revenue by Type (2013-2018)
Table North America and Europe Human Coagulation Factor VIII Revenue Share by Type (2013-2018)
Figure North America and Europe Recombinant Factor VIII Sales Growth (2013-2018)
Figure North America and Europe Recombinant Factor VIII Price (2013-2018)
Figure North America and Europe Plasma-derived Factor VIII Sales Growth (2013-2018)
Figure North America and Europe Plasma-derived Factor VIII Price (2013-2018)
Table North America and Europe Human Coagulation Factor VIII Sales by Application (2013-2018)
Table North America and Europe Human Coagulation Factor VIII Sales Share by Application (2013-2018)
Figure North America and Europe Hemophilia A Sales Growth (2013-2018)
Figure North America and Europe Spontanous / Trauma Sales Growth (2013-2018)
Figure North America and Europe Spontanous / Trauma Sales Growth (2013-2018)
Figure North America and Europe Other Sales Growth (2013-2018)
Figure United States Human Coagulation Factor VIII Revenue and Growth Rate (2013-2018)
Figure United States Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Table United States Human Coagulation Factor VIII Sales by Type (2013-2018)
Table United States Human Coagulation Factor VIII Sales Market Share by Type (2013-2018)
Table United States Human Coagulation Factor VIII Sales by Application (2013-2018)
Table United States Human Coagulation Factor VIII Sales Market Share by Application (2013-2018)
Table United States Human Coagulation Factor VIII Sales by Manufacturer (2016-2017)
Figure United States Human Coagulation Factor VIII Sales Market Share by Manufacturer in 2016
Figure United States Human Coagulation Factor VIII Sales Market Share by Manufacturer in 2017
Table United States Human Coagulation Factor VIII Revenue by Manufacturer (2016-2017)
Figure United States Human Coagulation Factor VIII Revenue Market Share by Manufacturer in 2016
Figure United States Human Coagulation Factor VIII Revenue Market Share by Manufacturer in 2017
Table United States Human Coagulation Factor VIII Export and Import (2013-2018)
Figure United Kingdom Human Coagulation Factor VIII Revenue and Growth Rate (2013-2018)
Figure United Kingdom Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Table United Kingdom Human Coagulation Factor VIII Sales by Type (2013-2018)
Table United Kingdom Human Coagulation Factor VIII Sales Market Share by Type (2013-2018)
Table United Kingdom Human Coagulation Factor VIII Sales by Application (2013-2018)
Table United Kingdom Human Coagulation Factor VIII Sales Market Share by Application (2013-2018)
Table United Kingdom Human Coagulation Factor VIII Sales by Manufacturer (2016-2017)
Figure United Kingdom Human Coagulation Factor VIII Sales Market Share by Manufacturer in 2016
Figure United Kingdom Human Coagulation Factor VIII Sales Market Share by Manufacturer in 2017
Table United Kingdom Human Coagulation Factor VIII Revenue by Manufacturer (2016-2017)
Figure United Kingdom Human Coagulation Factor VIII Revenue Market Share by Manufacturer in 2016
Figure United Kingdom Human Coagulation Factor VIII Revenue Market Share by Manufacturer in 2017
Table United Kingdom Human Coagulation Factor VIII Export and Import (2013-2018)
Figure Canada Human Coagulation Factor VIII Revenue and Growth Rate (2013-2018)
Figure Canada Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Table Canada Human Coagulation Factor VIII Sales by Type (2013-2018)
Table Canada Human Coagulation Factor VIII Sales Market Share by Type (2013-2018)
Table Canada Human Coagulation Factor VIII Sales by Application (2013-2018)
Table Canada Human Coagulation Factor VIII Sales Market Share by Application (2013-2018)
Table Canada Human Coagulation Factor VIII Sales by Manufacturer (2016-2017)
Figure Canada Human Coagulation Factor VIII Sales Market Share by Manufacturer in 2016
Figure Canada Human Coagulation Factor VIII Sales Market Share by Manufacturer in 2017
Table Canada Human Coagulation Factor VIII Revenue by Manufacturer (2016-2017)
Figure Canada Human Coagulation Factor VIII Revenue Market Share by Manufacturer in 2016
Figure Canada Human Coagulation Factor VIII Revenue Market Share by Manufacturer in 2017
Table Canada Human Coagulation Factor VIII Export and Import (2013-2018)
Figure Germany Human Coagulation Factor VIII Revenue and Growth Rate (2013-2018)
Figure Germany Human Coagulation Factor VIII Sales and Growth Rate (2013-2018)
Table Germany Human Coagulation Factor VIII Sales by Type (2013-2018)
Table Germany Human Coagulation Factor VIII Sales Market Share by Type (2013-2018)
Table Germany Human Coagulation Factor VIII Sales by Application (2013-2018)
Table Germany Human Coagulation Factor VIII Sales Market Share by Application (2013-2018)
Table Germany Human Coagulation Factor VIII Sales by Manufacturer (2016-2017)
Figure Germany Human Coagulation Factor VIII Sales Market Share by Manufacturer in 2016
Figure Germany Human Coagulation Factor VIII Sales Market Share by Manufacturer in 2017

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report